You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Aggressive Angiomyxoma of the Vulva: A Case Report and Review of the Literature

Sereda, Danya MD; Sauthier, Philippe MD; Hadjeres, Rachid MD; Funaro, Deana MD

Journal of Lower Genital Tract Disease:
doi: 10.1097/LGT.0b013e318180436f
Case Report
Abstract

Background. Aggressive angiomyxoma is a variant of myxoid neoplasms of the female pelvic soft parts. The term "aggressive" refers to the tumor's locally infiltrative and recurrent nature because distant metastases are rare.

Case. A 25-year-old woman presented with a 9-month history of an asymptomatic, polypoid mass arising from the right anterior labium minus. Histopathological and radiological examinations were consistent with a diagnosis of aggressive angiomyxoma. The patient was treated with a GnRH agonist followed by surgical excision.

Conclusion. We highlight the novel use of a GnRH agonist as a neoadjuvant to surgery in aggressive angiomyxoma to shrink the tumor preoperatively and decrease surgical morbidity.

In Brief

While definitive treatment of aggressive angiomyxoma is usually surgical, treatment with a GnRh agonist as a neo-adjuvant may be useful to shrink the tumor preoperatively.

Author Information

Service de Dermatologie, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada

Reprint requests to: Danya Sereda, MD. E-mail: dsereda@sympatico.ca

No financial support.

No disclaimers.

©2009The American Society for Colposcopy and Cervical Pathology